PAM
BMY icon

Palisade Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Palisade Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$950K Buy
16,490
+811
+5% +$46.6K 0.09% 126
2026
Q1 		$951K Sell
15,679
-136
-0.9% -$7.93K 0.1% 121
2025
Q4 		$853K Sell
15,815
-1,031
-6% -$49.6K 0.08% 122
2025
Q3 		$760K Sell
16,846
-739
-4% -$34.5K 0.07% 127
2025
Q2 		$814K Sell
17,585
-2,600
-13% -$128K 0.08% 126
2025
Q1 		$1.23M Sell
20,185
-130
-0.6% -$7.58K 0.13% 105
2024
Q4 		$1.15M Buy
20,315
+280
+1% +$15.6K 0.12% 112
2024
Q3 		$1.04M Buy
20,035
+1,926
+11% +$90.3K 0.1% 118
2024
Q2 		$752K Sell
18,109
-1,454
-7% -$65.1K 0.08% 133
2024
Q1 		$1.06M Buy
19,563
+225
+1% +$11.5K 0.1% 118
2023
Q4 		$992K Sell
19,338
-2,348
-11% -$123K 0.11% 120
2023
Q3 		$1.26M Buy
21,686
+760
+4% +$46.6K 0.15% 102
2023
Q2 		$1.34M Buy
20,926
+145
+0.7% +$9.72K 0.16% 103
2023
Q1 		$1.44M Sell
20,781
-184
-0.9% -$13K 0.18% 98
2022
Q4 		$1.51M Buy
20,965
+27
+0.1% +$2.04K 0.17% 100
2022
Q3 		$1.49M Buy
20,938
+11
+0.1% +$798 0.2% 89
2022
Q2 		$1.61M Sell
20,927
-138
-0.7% -$10.5K 0.21% 86
2022
Q1 		$1.54M Buy
21,065
+4,450
+27% +$299K 0.18% 95
2021
Q4 		$1.04M Sell
16,615
-1,380
-8% -$81K 0.12% 112
2021
Q3 		$1.06M Buy
17,995
+824
+5% +$54.3K 0.13% 110
2021
Q2 		$1.15M Buy
17,171
+437
+3% +$28.5K 0.13% 106
2021
Q1 		$1.06M Buy
16,734
+935
+6% +$58.2K 0.14% 107
2020
Q4 		$980K Hold
15,799
– – 0.13% 105
2020
Q3 		$953K Buy
15,799
+225
+1% +$13.5K 0.14% 100
2020
Q2 		$916K Sell
15,574
-157
-1% -$9.39K 0.15% 100
2020
Q1 		$877K Buy
15,731
+510
+3% +$31.2K 0.16% 94
2019
Q4 		$977K Buy
15,221
+1,621
+12% +$92.8K 0.14% 106
2019
Q3 		$690K Buy
13,600
+700
+5% +$32.9K 0.11% 113
2019
Q2 		$585K Buy
12,900
+480
+4% +$22.4K 0.09% 120
2019
Q1 		$593K Buy
12,420
+1,450
+13% +$72.2K 0.09% 124
2018
Q4 		$570K Buy
10,970
+325
+3% +$17.5K 0.08% 111
2018
Q3 		$661K Hold
10,645
– – 0.09% 112
2018
Q2 		$589K Buy
10,645
+850
+9% +$45.9K 0.09% 117
2018
Q1 		$620K Sell
9,795
-100
-1% -$6.43K 0.09% 115
2017
Q4 		$606K Hold
9,895
– – 0.1% 112
2017
Q3 		$631K Buy
9,895
+1,425
+17% +$83.2K 0.11% 98
2017
Q2 		$472K Hold
8,470
– – 0.09% 102
2017
Q1 		$461K Hold
8,470
– – 0.08% 104
2016
Q4 		$495K Sell
8,470
-1,587
-16% -$86.8K 0.09% 102
2016
Q3 		$542K Hold
10,057
– – 0.1% 97
2016
Q2 		$740K Sell
10,057
-625
-6% -$44.2K 0.14% 89
2016
Q1 		$682K Buy
10,682
+850
+9% +$53.6K 0.13% 90
2015
Q4 		$676K Sell
9,832
-1,138
-10% -$75.2K 0.14% 88
2015
Q3 		$649K Hold
10,970
– – 0.15% 90
2015
Q2 		$730K Sell
10,970
-199
-2% -$13.1K 0.15% 92
2015
Q1 		$720K Buy
11,169
+1,200
+12% +$75.1K 0.14% 89
2014
Q4 		$588K Hold
9,969
– – 0.12% 92
2014
Q3 		$510K Hold
9,969
– – 0.1% 96
2014
Q2 		$484K Hold
9,969
– – 0.1% 96
2014
Q1 		$518K Hold
9,969
– – 0.11% 94
2013
Q4 		$530K Sell
9,969
-1,801
-15% -$91.7K 0.12% 93
2013
Q3 		$545K Sell
11,770
-1,550
-12% -$68K 0.14% 87
2013
Q2 		$595K Buy
+13,320
New +$578K 0.15% 84

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Palisade Asset Management's BMY Position: Q2 2026 in Review

Palisade Asset Management increased its Bristol-Myers Squibb (BMY) stake by 5.2% in Q2 2026, buying an estimated $46.6K and bringing the position to 16,490 shares worth $950K. The position accounts for 0.09% of the portfolio, ranked #126.

Palisade Asset Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.61M in Q2 2022. 899 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Palisade Asset Management held 16,490 shares of Bristol-Myers Squibb worth $950K as of Q2 2026.
  • Palisade Asset Management bought 811 Bristol-Myers Squibb shares in Q2 2026, an estimated $46.6K.
  • Bristol-Myers Squibb made up 0.09% of Palisade Asset Management's portfolio in Q2 2026, its #126 holding.
  • Palisade Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Palisade Asset Management's Bristol-Myers Squibb position peaked at $1.61M in Q2 2022.
  • 899 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.